Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2018

Open Access 01-12-2018 | Research

Overactive bladder symptom severity, bother, help-seeking behavior, and quality of life in patients with type 2 diabetes: a path analysis

Authors: Dongjuan Xu, Meng Zhao, Liqun Huang, Kefang Wang

Published in: Health and Quality of Life Outcomes | Issue 1/2018

Login to get access

Abstract

Background

This study aimed to investigate the relationships among overactive bladder (OAB) symptom severity, bother, help-seeking behavior, and quality of life (QOL) in patients with type 2 diabetes.

Methods

A total of 127 diabetic patients, aged at least 18 years, with overactive bladder from a hospital in Shandong Province, China, were recruited for this study. Symptom severity, bother, and quality of life were assessed using the Overactive Bladder Symptom Score (OABSS), Patient Perception of Bladder Condition (PPBC), and Overactive Bladder Questionnaire Short Form (OAB-q SF), respectively. Help-seeking behavior was assessed by asking patients whether they consulted health care professionals or received treatment for their bladder problems. A two-step path analysis was performed to analyze the data.

Results

OAB symptom severity was directly associated with lower levels of QOL, and the strength of this association was no longer significant when taking bother and help-seeking behavior into account. Bother increased with OAB symptom severity, and patients with bothersome OAB tended to have lower levels of QOL. Moreover, bother increased help-seeking behavior; however, patients who sought help tended to have lower levels of QOL.

Conclusions

Our findings highlight the role of bother and help-seeking behavior in the relationship between OAB symptom severity and QOL. To improve a patient’s QOL, health care providers should focus not only on symptom bother but also on dysfunctional help-seeking patterns.
Literature
1.
Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An international Urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29:4–20.PubMed
2.
Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int. 2011;108:1132–8.CrossRefPubMed
3.
4.
Ganz ML, Smalarz AM, Krupski TL, Anger JT, JC H, Wittrup-Jensen KU, et al. Economic costs of overactive bladder in the United States. Urology. 2010;75:526–32.CrossRefPubMed
5.
Irwin DE, Mungapen L, Milsom I, Kopp Z, Reeves P, Kelleher C. The economic impact of overactive bladder syndrome in six western countries. BJU Int. 2009;103:202–9.CrossRefPubMed
6.
Inoue S, Kobayashi M, Sugaya K. Economic impact of overactive bladder symptoms in Japan. Nihon Hinyokika Gakkai Zasshi. 2008;99:713–22.PubMed
7.
Bartoli S, Aguzzi G, Tarricone R. Impact on quality of life of urinary incontinence and overactive bladder: a systematic literature review. Urology. 2010;75:491–500.CrossRefPubMed
8.
Sexton CC, Coyne KS, Thompson C, Bavendam T, Chen CI, Markland A. Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study. J Am Geriatr Soc. 2011;59:1465–70.CrossRefPubMed
9.
Vaughan CP, Johnson TM, Ala-Lipasti MA, Cartwright R, Tammela TL, Taari K, et al. The prevalence of clinically meaningful overactive bladder: bother and quality of life results from the population-based FINNO study. Eur Urol. 2011;59:629–36.CrossRefPubMed
10.
Gotoh M, Kobayashi T, Sogabe K. Characterization of symptom bother and health-related quality of life in Japanese female patients with overactive bladder. Neurourol Urodyn. 2015;34:730–5.CrossRefPubMed
11.
Homma Y, Gotoh M. Symptom severity and patient perceptions in overactive bladder: how are they related? BJU Int. 2009;104:968–72.CrossRefPubMed
12.
Irwin DE, Milsom I, Kopp Z, Abrams P, EPIC Study Group. Symptom bother and health care-seeking behavior among individuals with overactive bladder. Eur Urol. 2008;53:1029–39.CrossRefPubMed
13.
de Ridder D, Roumeguere T, Kaufman L. Overactive bladder symptoms, stress urinary incontinence and associated bother in women aged 40 and above; a Belgian epidemiological survey. Int J Clin Pract. 2013;67:198–204.CrossRefPubMed
14.
Botelho EM, Elstad EA, Taubenberger SP, Tennstedt SL. Moderating perceptions of bother reports by individuals experiencing lower urinary tract symptoms. Qual Health. 2011;21:1229–38.CrossRef
15.
Xu D, Wang X, Li J, Wang K. The mediating effect of 'bothersome' urinary incontinence on help-seeking intentions among community-dwelling women. J Adv Nurs. 2015;71:315–25.CrossRefPubMed
16.
Coyne KS, Sexton CC, Kopp Z, Chapple CR, Kaplan SA, Aiyer LP, et al. Assessing patients' descriptions of lower urinary tract symptoms (LUTS) and perspectives on treatment outcomes: results of qualitative research. Int J Clin Pract. 2010;64:1260–78.CrossRefPubMed
17.
Wennberg AL, Molander U, Fall M, Edlund C, Peeker R, Milsom I. Lower urinary tract symptoms: lack of change in prevalence and help-seeking behaviour in two population-based surveys of women in 1991 and 2007. BJU Int. 2009;104:954–9.CrossRefPubMed
18.
19.
Berges RR, Pientka L, Hofner K, Senge T, Jonas U. Male lower urinary tract symptoms and related health care seeking in Germany. Eur Urol. 2001;39:682–7.CrossRefPubMed
20.
Burgio KL, Goode PS, Johnson TM II, Hammontree L, Ouslander JG. Markland ADet al. Behavioral versus drug treatment for overactive bladder in men: the male overactive bladder treatment in veterans (MOTIVE) trial. J Am Geriatr Soc. 2011;59:2209–16.CrossRefPubMed
21.
Lofgren OE. Overactive bladder: a better understanding of pathophysiology, diagnosis and management. J Urol 2007;178:1553–53.
22.
Burgio KL, Goode PS, Richter HE, Markland AD, Johnson TM, Redden DT. Combined behavioral and individualized drug therapy versus individualized drug therapy alone for urge urinary incontinence in women. J Urol. 2010;184:598–603.CrossRefPubMed
23.
Karoli R, Bhat S, Fatima J, Priya SA. Study of bladder dysfunction in women with type 2 diabetes mellitus. J Endocrinol Metab. 2014;18:552–7.
24.
Palleschi G, Pastore AL, Maggioni C, Fuschi A, Pacini L, Petrozza V, et al. Overactive bladder in diabetes mellitus patients: a questionnaire-based observational investigation. World J Urol. 2014;32:1021–5.CrossRefPubMed
25.
Xu D, Gao J, Wang X, Huang L, Wang K. Prevalence of overactive bladder and its impact on quality of life in 1025 patients with type 2 diabetes in mainland China. J Diabetes Complicat 2017. 31:1254–8.
26.
Charlson ME, Pompei P, Ales KL, Mackenzie CRA. New method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefPubMed
27.
Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M, et al. Symptom assessment tool for overactive bladder syndrome – overactive bladder symptom score. Urology. 2006;68:318–23.CrossRefPubMed
28.
Hung MJ, Chou CL, Yen TW, Chuang YC, Meng E, Huang ST, et al. Development and validation of the Chinese overactive bladder symptom score for assessing overactive bladder syndrome in a RESORT study. J Formos Med Assoc. 2013;112:276–82.CrossRefPubMed
29.
Coyne KS, Matza LS, Kopp Z, Abrams P. The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder. Eur Urol. 2006;49:1079–86.CrossRefPubMed
30.
Coyne KS, Thompson CL, Lai JS, Sexton CC. An overactive bladder symptom and health-related quality of life short-form: validation of the OAB-q SF. Neurourol Urodyn. 2015;34:255–63.CrossRefPubMed
31.
LT H, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Modeling. 1999;6:1–55.CrossRef
32.
Takao T, Tsujimura A, Kiuchi H, Takezawa K, Okuda H, Yamamoto K, et al. Correlation between overactive bladder symptoms and quality of life in Japanese male patients: focus on nocturia. Urology. 2013;82:189–93.CrossRefPubMed
33.
Naliboff BD, Kim SE, Bolus R, Bernstein CN, Mayer EA, Chang L. Gastrointestinal and psychological mediators of health-related quality of life in IBS and IBD: a structural equation modeling analysis. Am J Gastroenterol. 2012;107:451–9.CrossRefPubMed
34.
Zhang L, Zhu L, Xu T, Lang J, Li Z, Gong J, et al. A population-based survey of the prevalence, potential risk factors, and symptom-specific bother of lower urinary tract symptoms in adult Chinese women. Eur Urol. 2015;68:97–112.CrossRefPubMed
35.
Gao J, Cheng R, Chen L, Wang X, Wang K. Help-seeking behavior among individuals with overactive bladder in type 2 diabetes mellitus and its influencing factors. Chin J Prac Nurs. 2016;32:571–5.
36.
Anger JT, Nissim HA, Le TX, Smith AL, Lee U, Sarkisian C, et al. Women's experience with severe overactive bladder symptoms and treatment: insight revealed from patient focus groups. Neurourol Urodyn. 2011;30:1295–9.PubMedPubMedCentral
37.
Coyne KS, Matza LS, Brewster-Jordan J. “We have to stop again?!”: the impact of overactive bladder on family members. Neurourol Urodyn. 2009;28:969–75.CrossRefPubMed
38.
Smith AL, Nissim HA, Le TX, Khan A, Maliski SL, Litwin MS, et al. Misconceptions and miscommunication among aging women with overactive bladder symptoms. Urology. 2011;77:55–9.CrossRefPubMed
39.
Siu YM. Communicating with mismatch and tension: treatment provision experiences of primary care doctors treating patients with overactive bladder in Hong Kong. BMC Fam Pract. 2015;16:160–70.CrossRefPubMedPubMedCentral
40.
Ellis TE. Learning cognitive-behavior therapy: an illustrated guide. B Menninger Clin. 2009;73:149–50.
Metadata
Title
Overactive bladder symptom severity, bother, help-seeking behavior, and quality of life in patients with type 2 diabetes: a path analysis
Authors
Dongjuan Xu
Meng Zhao
Liqun Huang
Kefang Wang
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2018
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-017-0829-z

Other articles of this Issue 1/2018

Health and Quality of Life Outcomes 1/2018 Go to the issue

Research

Comparing assessment of diabetes-related quality of life between patients and their physicians

Research

Functional status and annual hospitalization in multimorbid and non-multimorbid older adults: a cross-sectional study in Southern China

Research

Assessing whether EORTC QLQ-30 and FACT-G measure the same constructs of quality of life in patients with total laryngectomy

Correction

Correction to: Metformin improved health-related quality of life in ethnic Chinese women with polycystic ovary syndrome

Research

Can practitioners use patient reported measures to enhance person centred coordinated care in practice? A qualitative study

Research

Health-related quality of life in relation to symptomatic and radiographic definitions of knee osteoarthritis: data from Osteoarthritis Initiative (OAI) 4-year follow-up study